期刊文献+

环孢霉素A抑制肾性高血压大鼠心肌肥大的作用机制 被引量:3

The Mechanism By Which Cyclosporin A Inhibits Cardiac Hypertrophy in Renal Hypertension Rats
暂未订购
导出
摘要 目的 观察环孢霉素A对肾性高血压大鼠心肌肥大的抑制作用 ,并探讨其作用机制。方法  2 0只Wistar大鼠随机分为 3组 :两组采用一肾一夹模型制造肾性高血压 ,其中高血压组 (n =7)予生理盐水腹腔注射 ;CsA组 (n =7)给予环孢霉素A(CsA) 5mg·kg- 1 ·d- 1 腹腔注射 ;假手术组 (n =6)只给予生理盐水腹腔注射。称重法测定心重比 ,发色底物法测CaN活性 ;半定量PCR测定各组心肌组织中心房利钠因子 (ANF)及CaNmRNA的水平 ,同时用免疫组织化学染色方法 ,观察心肌中CaN及活化T细胞核因子 (nuclearfactorofactivatedTcell,NFAT)的表达。结果 肾性高血压大鼠经CsA干预 4周 ,其心重比较未干预组明显降低 (P <0 0 5 ) ,ANFmRNA水平较手术组明显降低 (P <0 0 5 ) ,与假手术组水平接近 ,心肌肥大受到抑制 ,同时发现心肌中CaN活性较未干预组显著下降 ,CaNmRNA水平较手术组明显降低 (P <0 0 5 ) ,免疫组化显示CsA干预组心肌中CaN及NFAT表达降低。 Objective To determine the mechanism by which Cyclosporin A(CsA) inhibits calcineurin(CaN)-dependent cardiac hypertrophy in renal hypertension rats. Methods The model of renal hypertension rats were established by the operation of “one kidney one clip(1K1C)”. Twenty Wistar rats were divided into 3 groups randomly: ①Hypertension group(n=7): 1K1C+0.9% NaCl 1 mL·kg -1·d -1 intraperitoneally and 0.9%NaCl in drinking of water for 4 weeks; ②CsA group(n=7):1K1C+CsA 5 mg·kg -1·d -1 intraperitoneally and 0.9% NaCl in drinking 4 weeks; ③sham operation group(n=6): sham operation +0.9% NaCl 1 mL·kg -1·d -1 intraperitoneally and in drinking for 4 weeks. The ratio of left ventricle weight to body weight(LW/BW) and the activity of CaN in the cardiac tissue were measured. Half quantitative PCR was employed to determine the levels of atrial natriuretic factor(ANF) mRNA and CaN mRNA in cardiac tissue. The expressions of CaN and NFAT (nuclear factor of activated T cell ) in cardiac tissue were examined by immunohistochemical staining. Results The ratio of LW/BW and activity of CaN in CsA group was decreased significantly compared with untreated group (LW/BW:0.27%±0.03% vs 0.35%±0.06%,P<0.05;CaN: 0.18±0.05 A410/mg protein vs 0.44±0.11 A410/mg protein, P<0.05). CaN and ANF mRNA level in CsA group was similar with that of sham operation group and much lower than that in untreated group(P<0.05). In CsA group, the lower expression of CaN and NFATc3 in cardiac tissue was also shown. Conclusion The preventive mechanism of CsA cardiac hypertrophy is related to the decrease of CaN expression and its activity in cardiac tissue.
出处 《高血压杂志》 CSCD 2004年第3期249-252,共4页 Chinese Journal of Hypertension
基金 "十五"军队医药卫生科研基金重点课题资助 (0 2Z0 1 0 )
关键词 高血压 肾性 左心室肥大 环孢霉素A 磷酸单酯水解酶类 hypertension, renal left ventricle hypertrophy cyclosporin A phosphoric monoester hydrolase
  • 相关文献

参考文献6

  • 1Hongo K,White E,Gannier F,et al .Effect of stretch on contraction and transient arrest ventricular muscles during hypoxia and acidosis[J ].Am J Physiol,1995,269: C690-697.
  • 2Sussman MA,Lim HW,Gude N,et al.Prevention of cardiac hypertrophy in mice by calcineurin inhibition[ J ].Science,1998,281:1690-1693.
  • 3符民桂,唐朝枢.钙调神经磷酸酶活性测定[J].中国动脉硬化杂志,2000,8(1):82-83. 被引量:26
  • 4Molkentin JD,Lu JR,AntosCL,et al.A calcineurin-dependent transcriptional pathwayfor cardiac hypertrophy[J].Cell,1998,17,93(2):215-28.
  • 5肖纯.肾性高血压发病机制及治疗进展[J].国外医学(生理病理科学与临床分册),1998,18(4):343-345. 被引量:7
  • 6Guerini D.Calcineurin: not just a simple protein phosphase[J].Biochem Biophys Res Commun,1997,235:271-275.

二级参考文献3

  • 1Molkentin J D,Cell,1998年,93卷,215页
  • 2Klee C B,J Biol Chem,1998年,273卷,13367页
  • 3Pallen C J,J Biol Chem,1983年,258卷,8550页

共引文献30

同被引文献47

  • 1谢晓华,常连庆,陈雯,宋立功,刘宁,张颖,孙愚,唐朝枢.外源性醛固酮调控大鼠心肌钙调神经磷酸酶的研究[J].解放军医学杂志,2004,29(9):798-800. 被引量:3
  • 2Ono K,Han J.The p38 signal transduction pathway:activation and function.Cell Signal,2000,12(1):1-13.
  • 3Passier R,Zeng H,Frey N,Naya FJ,Nicol RL,McKinsey TA,et al.CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.J Clin Invest,2000,105(10):1 395-406.
  • 4Lu J,McKinsey TA,Nicol RL,Olson EN.Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.Proc Natl Acad Sci U S A,2000,97(8):4 070-075.
  • 5McKinsey TA,Zhang CL,Lu J,Olson EN.Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation.Nature,2000,408(6808):106-111.
  • 6Frey N, Olson EN . Cardiac hypertrophy: the good, the bad, and the ugly.Annu Rev Physiol,2003,65: 45-79.
  • 7van Empel VP.De Windt LJ.Myocyte hypertrophy and apoptosis:a balancing act.Cardiovasc Res,2004,63(3): 487-499.
  • 8Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr, et al. Loss of a gp130 2cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress.Cell, 1999, 97 (2): 189-198.
  • 9Marin-Garcia J, Goldenthal MJ. Heart mitochondria signaling pathways:appraisal of an emerging field.J Mol Med,2004 82(9):565-578.
  • 10Kunisada K,Negoro S,Tone E,Funamoto M,Osugi T,Yamada S,etal.Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopsthy.Proc Natl Acad Sci USA,2000,97(1): 315-319.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部